Celgene
American biopharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Celgene?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).[2]
Quick Facts Company type, Industry ...
Company type | Subsidiary |
---|---|
Industry | Biotechnology |
Founded | 1986; 38 years ago (1986) |
Founder | Sol J. Barer |
Headquarters | Summit, New Jersey, U.S. |
Key people | Robert J. Hugin (Executive Chairman) Mark Alles (CEO) |
Products | Revlimid Abraxane Pomalyst/Imnovid Thalomid Idhifa |
Revenue | $15.281 billion (2018) |
$4.046 billion (2018) | |
Total assets | $35.480 billion (2018) |
Total equity | $6.161 billion (2018) |
Number of employees | 8,852 (2018) |
Parent | Bristol Myers Squibb |
Website | www |
Footnotes / references [1] |
Close